Literature DB >> 12643144

Osteoporosis and diabetes.

Diane L Chau1, Steven V Edelman, Manju Chandran.   

Abstract

Osteoporosis is the most prevalent metabolic bone disease in the United States. Although the disease has historically been reported mostly in white women, it can affect individuals of both sexes and all ethnic groups. The presence of osteoporosis related to diabetes is not well acknowledged and the impact of osteoporosis in a diabetic patient is often not considered. Routine screening or initiation of preventive medications for osteoporosis in all patients with type 1 or type 2 diabetes is not recommended at the present time. However, in all patients with diabetes, besides optimal glycemic control, general recommendations regarding adequate dietary calcium intake, regular exercise, and avoidance of other potential risk factors such as smoking should be given. In patients who have positive risk factors for osteoporosis, or in those who present with fractures, evaluation of bone density should be done and respective preventive or therapeutic interventions should be applied.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12643144     DOI: 10.1007/s11892-003-0051-8

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  43 in total

Review 1.  Role of exercise in preventing and treating osteoporosis.

Authors:  R Marcus
Journal:  Rheum Dis Clin North Am       Date:  2001-02       Impact factor: 2.670

Review 2.  [Skeletal effects of thiazolidinediones].

Authors:  R Okazaki
Journal:  Nihon Rinsho       Date:  2000-02

3.  A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.

Authors:  C H Chesnut; S Silverman; K Andriano; H Genant; A Gimona; S Harris; D Kiel; M LeBoff; M Maricic; P Miller; C Moniz; M Peacock; P Richardson; N Watts; D Baylink
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

4.  Psychiatric illness and mortality after hip fracture.

Authors:  S Nightingale; J Holmes; J Mason; A House
Journal:  Lancet       Date:  2001-04-21       Impact factor: 79.321

5.  Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.

Authors: 
Journal:  JAMA       Date:  1996-11-06       Impact factor: 56.272

6.  Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health Survey.

Authors:  L Forsén; H E Meyer; K Midthjell; T H Edna
Journal:  Diabetologia       Date:  1999-08       Impact factor: 10.122

7.  Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis.

Authors:  D Thiébaud; P Burckhardt; H Kriegbaum; H Huss; H Mulder; J R Juttmann; K H Schöter
Journal:  Am J Med       Date:  1997-10       Impact factor: 4.965

8.  Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women.

Authors:  K K Nicodemus; A R Folsom
Journal:  Diabetes Care       Date:  2001-07       Impact factor: 19.112

9.  Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover.

Authors:  R Okazaki; Y Totsuka; K Hamano; M Ajima; M Miura; Y Hirota; K Hata; S Fukumoto; T Matsumoto
Journal:  J Clin Endocrinol Metab       Date:  1997-09       Impact factor: 5.958

10.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

View more
  16 in total

1.  Decreased response of osteoblasts obtained from aged Cohen diabetic sensitive rats to sex steroid hormones and 1,25OH2D3 in culture.

Authors:  Asher Ornoy; Perchia Yaffe; Sarah W Zangen; Nathan Patlas; Zvi Schwartz
Journal:  Odontology       Date:  2006-09       Impact factor: 2.634

Review 2.  The Emerging Role of Non-Coding RNAs in Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells.

Authors:  Xiaoying Chen; Wei Xie; Ming Zhang; Yuhan Shi; Shaofen Xu; Haoyu Cheng; Lihong Wu; Janak L Pathak; Zhichao Zheng
Journal:  Front Cell Dev Biol       Date:  2022-05-16

Review 3.  A new perspective on mechanisms governing skeletal complications in type 1 diabetes.

Authors:  Zeynep Seref-Ferlengez; Sylvia O Suadicani; Mia M Thi
Journal:  Ann N Y Acad Sci       Date:  2016-08-29       Impact factor: 5.691

4.  Spontaneous bone loss in RIP-iNOS transgenic mouse: a mouse model for diabetes-mediated osteopenia/osteoporosis.

Authors:  Qing-Sheng Mi; Sheng-Li Yan; Zai-Zhao Wang; Ke-Hong Ding; Changgui Li; Luan Wang; Li Zhou; Yasuhiko Yamamoto; Hiroshi Yamamoto; Hiroshi Okamoto; Carlos Isales
Journal:  Cell Cycle       Date:  2009-12-21       Impact factor: 4.534

5.  Proteomic identification and immunolocalization of increased renal calbindin-D28k expression in OVE26 diabetic mice.

Authors:  Visith Thongboonkerd; Shirong Zheng; Kenneth R McLeish; Paul N Epstein; Jon B Klein
Journal:  Rev Diabet Stud       Date:  2005-05-10

Review 6.  Glucagon-like peptide-1(GLP-1) receptor agonists: potential to reduce fracture risk in diabetic patients?

Authors:  Guojing Luo; Hong Liu; Hongyun Lu
Journal:  Br J Clin Pharmacol       Date:  2016-01       Impact factor: 4.335

7.  Organ-based response to exercise in type 1 diabetes.

Authors:  Lisa Stehno-Bittel
Journal:  ISRN Endocrinol       Date:  2012-12-02

8.  Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.

Authors:  Sang-Yong Han; Kyung-Hee Lee; Yun-Kyung Kim
Journal:  Int J Mol Med       Date:  2018-03-30       Impact factor: 4.101

9.  Prevalence of Osteoporosis and Its Associated Factors among Older Men with Type 2 Diabetes.

Authors:  Hai-Ling Chen; Li-Li Deng; Ju-Fen Li
Journal:  Int J Endocrinol       Date:  2013-01-17       Impact factor: 3.257

10.  Increased Risk of Osteoporosis in Depressive Patients with Erectile Dysfunction: A Cross-sectional Study from Malaysia.

Authors:  Abdul Rahman Fata Nahas; Syed Azhar Syed Sulaiman
Journal:  J Pharm Bioallied Sci       Date:  2017 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.